Clinical research of dexmedetomidine for inhibiting remifentanil-induced hyperalgesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003731

Enrollment

Unknown

Registered

2013-10-20

Start date

2013-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholecystectomy

Interventions

dexmedetomidine(D) group:given dexmedetomidine 15 min before the induction of anesthesia using up-and-down method

control group:normal saline was given to the patients in group C,15 min before the induction of anesthesia.

Eligibility

Sex/Gender

All

Age

25 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients are scheduled to receive general anaesthesia for laparoscopic cholecystectomy.

Exclusion criteria

Exclusion criteria: unable to comprehend visual analog scale(VAS);took analgesics regularly or had used opioids within 12 h of surgery.

Design outcomes

Primary

Measure	Time frame
The VAS scores;	—

Secondary

Measure	Time frame
Duration of surgery;Remifentanil dose;	—

Countries

China

Contacts

Public ContactHang Li-hua

the First People's Hospital of Zhenjiang

378805181@qq.com+86 18952898746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026